Philip Morris
Risk Analysis in Occupational and Environmental Health 910904 - 910906
Fields
- Type
- REPT, REPORT, OTHER
- AGEN, AGENDA
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- DRAW, DRAWING
- FOOT, FOOTNOTES
- LIST, LIST
- PHOT, PHOTOGRAPH
- AGEN, AGENDA
- Attendee (Organization)
- American Lung Assn
- American Petroleum Inst
- Atlantic Env + Marine Services
- Barr Engineering
- Cdrh
- Division of Life Sciences
- Dls
- Dow Chemical
- Drackett
- Ecology + Environment
- Economic Research Service
- Ed
- Ef
- Eg+G
- Enviromed
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Forces Command
- Hazardous Contaminants Branch
- Il Dept of Nuclear Safety
- John Mathes + Associates
- Kcmo Fire Dept
- Korean Ministry of Environment
- Lawrence Livermore Natl Lab
- Medical College of Wi Milwaukee
- Mro
- Mropot
- Natl Toxics Campaign Fund
- Navy Environmental Health Center
- Niosh, Natl Inst for Occupational Safety & Health
- Nus
- Ny State Low Level Radioactive Waste Sit
- Obrien + Gere Engineers
- Omaha District Corps of Engineers
- Ontario Ministry of the Environment
- Ost
- Ows
- Portsmouth Naval Shipyard
- Rohm Haas Uk
- SC Johnson + Son
- Schlumberger Env Svces
- Usace
- Xerox
- American Petroleum Inst
- Area
- LOGUE,MAYADA/OFFICE
- Site
- N426
- Request
- Stmn/R1-072
- Named Organization
- Univ of Ne Omaha
- Univ of Oxford
- US Public Interest Research Group
- Usgs
- Wed
- Ahmed
- Associated Press
- Beth Israel Hospital
- Boston Hospital for Women
- Brooklyn College
- Cambridge Environmental
- Cdc
- Childrens Cancer Research Foundation
- Childrens Hospital Medical Center
- Congress
- Conservation Law Foundation
- Criminal Division
- Ct Dep
- Ct Dept of Health Services
- Ct Legislature
- Environ Toxicology Div
- Environmental Defense Fund
- Environmental Epidemiology + Toxicology
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Federal Register
- Gradient
- Harvard Boston
- Harvard Univ Cambridge
- Health Effects Research Lab
- Hew, Dept of Health Education and Welfare
- Joint Working Comm
- Justice Dept
- Ma Mental Health Center
- Marsh Mclennan
- Mbta
- Morgan Lewis
- New England Deaconess Hospital
- Nlm
- Ny Univ
- Office of Drinking Water
- Office of Toxicological Sciences
- Peter Bent Brigham Hospital
- Preventive Disease Division
- Rapid Transit Lines
- Science
- Senate
- Uc Berkeley
- Univ of Al Birmingham
- Univ of Oxford
- Named Person
- Albert
- Ames
- Angell
- Baker
- Bellinger
- Birnbaum, L.
- Brain, J.D.
- Brown, D.R.
- Bush
- Butt
- Calabrese
- Cohen, S.M.
- Cole, P.
- Cools
- Covington, P.
- Crouch, Eac
- Dennis, E., J.R.
- Dietrich
- Doll, R.
- Dunster, J.
- Ernhart
- Foy, D.
- Fulton
- Goldsmith
- Goldwater
- Graham, J.D.
- Hammond
- Harley
- Hawk
- Hecker
- Hofreuter
- Hu, H.
- Johnson
- Joselow
- Kaplan
- Kehoe
- Kneip
- Lacey
- Landrigan
- Letonoff
- Mclaughlin
- Mcmillen
- Moeller, D.W.
- Monson
- Oleary, J.F.
- Osborne
- Perkins
- Peto, R.
- Phillips
- Piomelli
- Rabinowitz
- Ryan, P.B.
- Ryu
- Scheuplein, R.
- Schroeder
- Schwartz
- Sherlock
- Siegel
- Smith
- Tepper
- Thornburgh, D.
- Upton, A.C.
- Valberg, P.A.
- Weiliang
- Wilson, R.
- Balserak, P.
- Banikowski, J.
- Boeniger, M.
- Coferwildsmith, M.
- Cotter, S.A.
- Dymond, M.
- Ellam, N.
- Gagen, A.A.
- Gallina, C.O.
- Giles, Y.M.
- Goodale, B.G.
- Grilli, F.
- Grossberg, S.E.
- Gunn, M.
- Hagen, A.A.
- Hayes, W.C.
- Hernandez, J.E.
- Hernandez, O.
- Jennett, L.E.
- Kim, J.S.
- Kuhn, B.
- Kutcher, J.
- Limuller, A.
- Logue, M.
- Mead, H.E.
- Mermelstein, R.
- Meteyer, M.
- Noorani, Y.G.
- Osimitz, T.G.
- Rasmussen, S.
- Ruble, B.R.
- Salladay, J.
- Seiter, T.
- Selcoe, B.
- Smith, R.C.
- Stark, R.
- Tilson, P.
- Vandegriek, A.
- Walker, S.R.
- Willard, T.
- Willwerth, E.J.
- Youngs, F.
- Ames
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Author (Organization)
- Harvard Boston
- Master ID
- 2025545673/6381
Related Documents:- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- ILLE, ILLEGIBLE
- MARG, MARGINALIA
- PARE, PARENT
- MARG, MARGINALIA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- sjp02a00
Document Images
2025545687

2
Bruce G. Goodale
Environmental Project Director
NY State LOw Level Radioactive
Waste Siting Commission
2 Third Street
Troy, NY a2180
518-271-1;585 Oscar Hernandez
Branch Chief
US Environmental Protection Agency
11903 Antietam Road
Woodbridge, VA 22192
Franca Gri1 l i
Assistant Regulatory Toxicologist
Hazardous Contamination Branch
Ministry of' the Environment
135 St. C1' a.i r Avenue West Linda E. Jennett
Director Environmental Affairs
Schlumberger Env. Svces., Inc.
300 N. Main St., Suite 200
Greenville, SC 29601
803-233-0916
Suite 100
Toronto, Ontario, CAN M4V1P5
416-323-5076
Jong-Suk Kim
Sidney E. Grossberg, M.D.
Professor and Chairman
Department of Microbiology Director-General
Korean Ministry of Environment
635-298 Pongcheon 9-dong, Kwank-gu
Seoul, Korea
617-432-4637
Medical College of Wisconsin
8701 Watert,Dwn Plank Rd.
Milwaukee, WI 53226
414-257-8427
Betsey Kuhn
Deputy Director
Michael Gunn
Asst. to the City manager
City of Cincinnati Resources & Technology Division
Economic Research Service
1301 New York Avenue, NW
Washington, DC 20005
202-219-0449
801 P1 um Street, Rm. 24
Cincinnati, OH 45202
513-352-3790
Jeffrey Kutcher
Aanel i a A. Hagen
Acting Group Leader
Lawrence Livermore National Lab Consutants in Epidemiology and
Occupational Health
2428 Wisconsin Ave., NW
Washington, DC 20007
202-333-2364
P0 Box 808, 7000 East Ave, L-255
Livermore, CA 94551
415-422-4278
Angela Li-Muller
William C. Hayes
Environmental Specialist
Dow Chemical Company Senior Regulatory Toxicologist
Ontario Ministry of the Environment
135 St. Clair Ave West
Toronto, Ontario M4V 1P5
416-323-5114
V
2020 Dow Center
Midland, MI 48674
517-636-2664
Mayada Logue O
N
~11
Scientist
Philip Morris v't
~
Jose E. Hernandez P0 Box 26603
Head, Indusi:ri al Hygi ene Dept. Richmond, VA 23261 ~
Navy Environrriental Health Center 804-274-3189 ~
2510 Walmer Ave. ©
Norfolk, VA 23664
804-444-7575

TO: Continuing Education Participant~s ~
FROM: David A. S. Klipp, Program Coordinator
RE: Telephone Locations and Protocol
Here are the-telephone numbers which will serve to deliver
messages to you during your stay with us at Harvard:
During Class Hours: 617-432-1109
if that line is busy or there is no answer:
617-432-1171.
We will take messages for you and post them either at the back of the
classroom or at your place. In the event of an emergency, we will
interrupt you in class.
Here is-a- map-indicating (**)-the locations of the -four--public
telephones in the School of Public Health:
Lounge ** ~ ** (1st Floor)
_ T
I~
Elevators 11{11(stairway)
--
'
\/
\)
Classroom Hallway
Lavatories
PLEASE NOTE:
~
O
~
~
Acknowledging the limited number of public telephones available C1Y
here, we ask that you please try to consider keeping your calls 1$
brief and to a minimum. ~
~
~

i
V
A
®
M1!®ENTL4L
.114M l.r
LucMrsllt ®
SCIEMCS PARK
NORTH STATtOf!
MAY1iA!lRST
VowooIN*hm
aO'VtRM1iEHT CTRI
L PARK sT/IEST
A~aa~®w~
C®MMUTElI /RAEte LiNlt docrun
. av.k43T~~oa 
HARVARD MEDICAL AREA
IKEY TO uaAPf
I Rotch Bulldinp- 55 Shattuck Stre.t OTHER MEDICAL AREA FACILITIES
14
New Engiand Deaconeu Hoipital
HARVAR D SCHOOL OF PUBLIC HEALTH Francis A. Countway Librory of M.dklns
15
Beth Israel Hospital
2
Heelth Scimces :aboratovies, Dldgs, I ord 11 10 Shattuck Strett
16
Judqe Baker Guidance Center
665 Huntinpton Avenuo 9 Peter Bent Bripham HospitN
17
Boston Hospitat for Women (Lyin¢In Divkion)
10 Massochusatts MentaJ Health Canter
3 Sebastian S. Krage Educ®tiond F.cilidp Sullding
1e
Madicat Ar®. Coop:
677 Huntlnptonb Avanut 11 Chlldren's Cancer Research Foundatlon
19 Jimmy Fund Auditorium
4 Henry LnSh.ttuclc International Houe. 12 Childnn'e Hospitd Medicta CentM
189-203-207 Park Drhrt 20 Harvard M.dicat School Labontory for Human
13 Shields Warren Radiation Latwr.tory Reproductlon.nd Repeoductive Biology
HARVARD MEDICAL SCHOOL
S Medical School Uwtdrangla 25 Shattuck ;itre.t
5A Harvard M.dica! School -Adminimadon Wpdky
3 V.nderbilt H.II -- 109 Av®nue Loui. P..tses
(Medkal H.atth S.rvkatl
HARVARD SCHOOL OF DENTAL MEDICINE
7 Hanard Schoot of Dantd M.edicin.
188 Lonp+vocb Av.atus
Shattuck In-
~ternational
House

SCIENCE AND ITS
LIIVIa[TSo The
Regulator's Dilemma
Alvin M. Weinberg
PROLOGUE: The shift in environmental concerns from visible pollution to
more subtle threats, such as toxic pollutanis, presents special problems for
regulators xho must fi4nction outside the limits of scientific certainly. The
same handicap besets judges who tnust adjudicate disputes over claims for
damages arising from new and hazardous technologies that involve adverse
health effects that are latent or unpredictable.
In this area of uncertainty in which accidental exposure to hazards is
rare, scieni'i;,,ts resort to probabilistic risk assessment to estimate the likeli-
hood and consequences of events that may carry a threat to human health.
Such scienti,6c techniques for the investigation of rare events, however, often
cannot provide definitive answers for regulators and judges.
In this essaY phtsicist .9lvin Id'einberg suggests that instead of asking sci-
entists for answers to unanswerable questions, regulators should settle for
less-definitive answers and regulate on the basis of uncertainty. Technologi-
cal ftxes, including greater reliance on inherent safetyfeatures that depend
on the imnnutable laws of nature, can help reduce risk. But ultimately, says
ti'einberg, it tna' y be necessary to establish some threshold beyond which
blame for accidents and other untoward events would be unprovable and vic-
tims would be compensated by a society as a whole. t
Alvin A1. Id'einberg received his Ph.D. in physics from the University of
Chicago in i' 939. He has been a leading figure in the development of nu-
clear energy and has served as director of the Oak Ridge National Labora-
ton- and as director of the Institute for Energy Analysis of the Oak Ridge
Associated Universities. He is the coauthor of The Physical Theory of Neu-
tron Chain Reaction (1958) and has written extensivelv on nuclear energy,
nuclear proliferation, and the interaction between modern technology and
s(X'iet 1'.
FALL 1985 59

Despite the difficulties, scientific mechanisms have been devised for
estimating, however imperfectly, the probability of rare events. For accidents
the technique is probabilistic risk assessment (PRA); for low-level insults
various empirical and theoretical approaches are used.
Although probabilistic risk assessment had been used in the aerospace
industry for a long time (for example, to predict the reliability of compo-
nents), it first sprang into public prominence in 1975 with a reactor safety
study directed by nuclear engineer Norman C. Rasmussen.3 The Rasmussen
study, sponsored by the Atomic Energy Commission (now known as the
Nuclear Regulatory Commission), was designed to estimate the public risks
involved in potential accidents at commercial nuclear reactors.
Probabilistic risk assessment, when applied to nuclear reactors, seeks to
identify all sequences of subsystem failures that may lead to a failure of the
overall system; it then tries to estimate the consequences of each subsystem
failure so identified. The result is a probability distribution, P(C): that is., the
probability, P, per reactor year, of a consequence having magnitude C.
Consequences include both material damage and health effects. Usually, the
probability of accidents having large consequences is less than the probability
of accidents having small consequences.
A probabilistic risk assessment for a reactor requires two separate
estimates: first, an estimate of the probability of each accident sequence;
second, an estimate of the consequences-particularly the damage to human
health-caused by the uncontrolled radioactive effluents released in the
accident. An accident sequence is a series of equipment or human malfunc-
tions, such as a pump that fails to start, a valve that does not close, or an oper-
ator confusing an ON with an OFF signal. We have statistical data for many of
these individual events; for example, enough valves have operated for enough
years so that we can, at least in principle, make pretty good estimates of the
probability of failure.
Uncertainties still remain, however, because we can never be certain that
we have identified every relevant sequence. Proof of the adequacy of proba-
bilistic risk assessment must therefore await the accumulation of operating
experience. For example, the median probability of a core melt in a light water
reactor, according to the 1975 Rasmussen study, was I in every 20,000
reactor-years; the core melt at Three Mile Island's number two reactor (TMI-
2) occurred after only 700 reactor-years. The number two reactor, however,
differed from the reactors Rasmussen studied, and in retrospect, one could
rationalize most of the discrepancy between his estimate and the seemingly
premature occurrence at TMI-2.
Since the core melt at Three Mile Island. the world's light water reactors
have accumulated some 1,500 reactor-years of operation without a core melt.
This performance places an upper limit on the a priori estimate of the core-
melt probability. Thus. if this probability were as high as I in every 1,000
reactor vears. the likelihood of su5iving 1,500 reactor-years would not be
more than 22 percent; put otherwise, we can say with 78 percent confidence
that the core-melt probability is not as high as I in 1,000 reactor years. With
500 light water reactors on line in the world, should we survive until the year
2000 without another core melt, we could then say with 95 percent confidence
62 ISSI!ES IN SCIENCE AND TECH'.OLOG1'

I n his essay "Risk, Science, and Democracy," William D. Ruckelshaus
expresses very clearly what I call the regulator's dilemma. During the
past 15 years. Ruckelshaus notes, there has been a shift in public
emphasis from visible and demonstrable pollution problems, such as
smog resulting from automobiles and raw sewage, to potential and largely
invisible problems, such as the effects of low concentrations of toxic pollutants
on human health. This shift is important for two reasons. First, it has changed
the way that science is applied to practical questions of public health
protection and environmental regulation. Second, it has raised difficult
questions about managing chronic risks within the context of free and
democratic institutions.z
When the environmental concern was patent and obvious-such as the
problem of smog in Los Angeles-science could and did provide unequivocal
answers. Smog, for example, comes from the gas emissions from burning
liquid hydrocarbons, and the answer to the smog problem lies in controlling
these emissions. The regulator's course was rather straightforward because the
science upon which regulatory decisions are made was operating well within
its power. However, when the environmental concern is subtle-for example,
how much cancer is caused by an increase of 10 percent in mean background
radiation-science is being asked a question that lies beyond its power; the
question is trans-scientific. Yet the regulator, by law, is expected to regulate
even though science can hardly help him; this is the regulator's dilemma.
Although my essay is subtitled The Regulator's Dilemma, many of the
same issues anse in the adjudication of disputes over who is to blame and who
is to be compensated for damage allegedly caused by rare events, such as
nuclear accidents. The regulator's dilemma is also faced by the judge who is
presiding over a tort case involving, for example, a claim for damages blamed
on a toxic waste dump. Indeed, the regulator's dilemma could equally be
called the toxic tort dilemma.
A lawsuit involving alleged injury from chemical pollutants is unlike the
traditional liability case. If my car injures a pedestrian, I am liable to be sued.
What is at issue, however, is not whether I have injured a pedestrian. Rather, it
is whether I am at fault. On the other hand, if the lead from my car's exhaust is
alleged to cause bodily harm, the issue is not whether my car emitted the lead
but whether the lead actually caused the alleged harm. The two situations are
quite diffetent.. In the first example the relation between cause and injury is
not at issue. In the second it is the issue.
In this essay, therefore, I try to delineate more precisely those limits to sci-
ence that give rise to the regulator's dilemma. I speculate on how these
intrinsic limits to science seem to have catalyzed a profound attack on science
by some sociologists and public-interest activists. In addition, I offer a few
ideas that may help the harried regulators finesse these trans-scientific issues.
I I
Science deals with regularities in our experience; art deals with
singularities. It is no wonder that science tends to lose its predictive or even
explanatory power when the phenomena it deals with are singular,
60 ISSUES IN SCIENCE AND TECHNOLOGY

Ii. Supreme Qturt of the United States: Industrial Union Depanment,
AFl: CIO v. American Petroleum Institute. et al., argued October 10.
19'9. dee:ided July 2. 1980. No. .'8-911. Washington, DC (1980).
IG. Anierican Industrial Health Council: Q mment on: A Rep ut < f the
GueraKenq- Regulatory Liaix>n Group Entitled ':ticientific Ba.u~ for
Ielentif}inK Potential Carcinogens and Estimating their Ri,k." AIHC.
"iar.uLle. ( btay S. 19-9 ).
17. Purchase, LF.: Inter,pecies Compari.xxts of Carcinogenicity. Br. J.
Cancer 41:454-46K (19ki0).
18. l'.S. EmOronmerttal Protection Agency: Policy and Procedures for
IdentiF<ing, and A,sessinR and Regulating Airtx)rne Substances Pc .tiinR
a Risk of Cancer. Pr<tpu ecl Rule Fed. Reg. a4:5£3(i42 (19t30).
Received 8 28r89: review decision 12/t/89; revision 2/8190; accepted 3/9/90
APPL OCCUP. ENVIRON. HYG. 5/8) AUGUST 1990 517

Instead of asking
science for answers to
unanswerable
questions, regulators
should be content
wa th less far-reach i ng
answers.
negotiation between individuals in conflict because they hold different non-
scientific beliefs, how can one say that this scientist's opinion is preferable to
that one's? Furthermore, if the matter at issue moves across the boundary
between science and trans-science, where all we can say with certainty is that
uncertainties are very large, how much less able are we to distinguish between
the expert and the charlatan, between the scientist who tries to adhere to the
usual norms of scientific behavior and the scientist who suppresses facts that
conflict with his political, social, or moral preconceptions?
One way to deal with these assaults on scientists and scientific truth
would be to define a new branch of science, called regulatory science, in which
the norms of scientific proof are less demanding than are the norms in
ordinary science. I should think that a far more honest and straightforward
way of dealing with the intrinsic inability of science to predict the occurrence
of rare events is to concede this limitation and not to ask of science or
scientists more than they are capable of providing. Instead of asking science
for answers to unanswerable questions, regulators should be content with less
far-reaching answers. For example, where the ranges of uncertainty can be
established, regulate on the basis of uncertainty; where the ranges of uncer-
tainty are so wide as to be meaningless, recast the question so that regulation
does not depend on answers to the unanswerable. Furthermore, because these
same limits apply to litigation, the legal system should recognize, much more
explicitly than it has, that science and scientists often have little to say,
probably much less than some scientific activists would admit.
The expertise of scientific adversaries is often at the heart of litigation
over personal injury alleged to be caused by subtle, low-level exposures. Each
side presents witnesses whose scientific credentials it regards as impeccable.
Because the issues themselves tend to be trans-scientific, one can hardly
decide the validity of the assertions of either side's witnesses. Under the
circumstances, I suppose, one is justified in regarding a scientific witness no
differently than any other witness; his credibility is judged by his past record,
behavior, and general demeanor, as well as the self-consistency of his testi-
mony. Such, at least, was the way in which a federal district court judge,
Patrick Kelley, settled Johnston v. United States, in which the issue was the
claim that exposure to radiation from reworking old aircraft instrument dials
had caused injury; Kelley impugned, on grounds no different from those one
would invoke in an ordinary lawsuit, the competence if not the integrity of
some of the plaintiffs scientific witnesses.
VII
There are various ways to provide some assurance of safety despite
uncertainty. Here I briefly describe two of these ways-which I call the
technological fix and de minimis-without claiming that these are the most
important, let alone the only, ones.
Technological fix. Science cannot exactly predict the probability of a
serious accident in a light water reactor or the likelihood that a radioactive
waste canister in a depository will dissolve and release radioactivity to the
environment. Can one design reactors or waste canisters for which the
68 ISSUES IN SCIENCE AND TECHNOLOGY
